Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
25,099,442
-
Shares change
-
+2,282,234
-
Total reported value, excl. options
-
$301,208,568
-
Value change
-
+$26,792,518
-
Number of buys
-
37
-
Number of sells
-
-36
-
Price
-
$12
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q1 2017
93 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q1 2017.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,099,442 shares
of 37,435,082 outstanding shares and own 67.05% of the company stock.
Largest 10 shareholders include NWQ INVESTMENT MANAGEMENT COMPANY, LLC (3,708,408 shares), FRANKLIN RESOURCES INC (2,847,200 shares), WYNNEFIELD CAPITAL INC (2,682,400 shares), DIMENSIONAL FUND ADVISORS LP (2,290,391 shares), BlackRock Inc. (1,849,477 shares), VANGUARD GROUP INC (1,254,994 shares), ROYCE & ASSOCIATES LP (1,037,507 shares), HEARTLAND ADVISORS INC (961,950 shares), ROYAL BANK OF CANADA (897,867 shares), and THOMSON HORSTMANN & BRYANT INC (884,279 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.